Buy or sell BioCatch stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

BioCatch Stock

BioCatch is a cybersecurity company that delivers behavioral biometrics, analyzing human-device interactions to protect users and data.

Founded

2011

Total Funding

$41.6M

About BioCatch Stock

Based in Boston, Massachusetts, BioCatch offers a range of behavioral authentication and threat detection solutions for web and mobile applications. Available as a cloud-based solution, BioCatch collects and analyzes more than 2000 cognitive parameters to generate unique user profiles. Organizations use the platform to continuously authenticate users during their online sessions, protecting against cyber threats and fraudulent activity, such as account takeover and RAT-in-the-Browser (RitB), remote access, and automated account manipulation. BioCatch was founded in 2011.

Funding History

March 2012$600K
September 2013$1.0M
June 2014$10.0M
March 2018$30.0M

Management

Founder, CTO & VP Business Development

Avi Turgeman

CEO

Howard Edelstein

Chief Strategy & Marketing Officer

Frances Zelazny

Head of Cyber Strategy

Uri Rivner

Director of Cyber Strategy US

Zach Dahlgren

CFO

Richard Sheldon

Manager Strategic Accounts and Global Alliances

Jay Whoriskey

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from BioCatch or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo